icon
icon
Back to University

Translational Virology

Publications

  • Saraf A, Gurjar R, Kaviraj S, Kulkarni A, Kumar D, Kulkarni R, Virkar R, Krishnan J, Yadav A, Baranwal E, Singh A, Raghuwanshi A, Agarwal P, Savergave L, Singh S; GEMCOVAC-OM Study Investigators. An Omicron-specific, self-amplifying mRNA booster vaccine for COVID-19: a phase 2/3 randomized trial. Nat Med. 2024 Apr 18. doi: 10.1038/s41591-024-02955-2. Epub ahead of print. PMID: 38637636.
  • Vedpathak S, Sharma A, Palkar S, Bhatt VR, Patil VC, Kakrani AL, Mishra A, Bhosle D, Arankalle VA, Shrivastava S. Platelet derived exosomes disrupt endothelial cell monolayer integrity and enhance vascular inflammation in dengue patients. Front Immunol. 2024 Jan 3;14:1285162. doi: 10.3389/fimmu.2023.1285162. PMID: 38235130; PMCID: PMC10791899.
  • Giri S, Chhabra P, Kulkarni R, Reju S, Sabapathy SK, Selvarajan S, Varghese T, Kalaivanan M, Dorairaj P, Kalrao V, Mankar S, Sangamnerkar M, Chethrapilly Purushothaman GK, Srikanth P, Kang G, Vinjé J. Hospital-based norovirus surveillance in children <5 years of age from 2017 to 2019 in India. J Med Virol. 2024 Jan;96(1):e29384. doi: 10.1002/jmv.29384. PMID: 38235830; PMCID: PMC10875411.

  • Gunale B, Farinola N, Yeolekar L, Shrivastava S, Girgis H, Poonawalla CS, Dhere RM, Arankalle V, Chandra Mishra A, Mehla R, Kulkarni PS. A Phase 1, double-blind, randomized, placebo-controlled study to evaluate the safety and immunogenicity of a tetravalent live attenuated dengue vaccine in adults. Vaccine. 2023 Aug 31;41(38):5614-5621. doi: 10.1016/j.vaccine.2023.07.045. Epub 2023 Jul 31. PMID: 37532611.
  • Gosavi M, Kulkarni-Munje A, Patil HP. Dual pattern recognition receptor ligands CL401, CL413, and CL429 as adjuvants for inactivated chikungunya virus. Virology. 2023 Aug;585:82-90. doi: 10.1016/j.virol.2023.06.001. Epub 2023 Jun 11. PMID: 37321145.
  • Patil R, Palkar S, Mishra A, Patil R, Arankalle V. Variable neutralizing antibody responses to 10 SARS-CoV-2 variants in natural infection with wild- type (B.1) virus, Kappa (B.1.617.1), and Delta (B.1.617.2) variants and COVISHIELD vaccine immunization in India: utility of the MSD platform. Front Immunol. 2023 Jun 5;14:1181991. doi: 10.3389/fimmu.2023.1181991. PMID: 37342350; PMCID: PMC10277512.
  • Doke PP, Mhaske ST, Oka G, Kulkarni R, Muley V, Mishra AC, Arankalle VA. SARS-CoV-2 breakthrough infections during the second wave of COVID-19 at Pune, India. Front Public Health. 2023 Jan 12;10:1040012. doi: 10.3389/fpubh.2022.1040012. PMID: 36711329; PMCID: PMC9877521.

  • Arankalle VA, Kulkarni-Munje A, Kulkarni R, Palkar S, Patil R, Oswal J, Lalwani S, Mishra AC. Immunogenicity of two COVID-19 vaccines used in India: An observational cohort study in health care workers from a tertiary care hospital. Front Immunol. 2022; In press.
  • Gosavi M, Patil HP. Evaluation of monophosphoryl lipid A as an adjuvanted for inactivated chikungunya virus. Vaccine. 2022 Aug 12;40(34):5060-5068. doi: 10.1016/j.vaccine.2022.07.018. Epub 2022 Jul 21. PMID: 35871870.
  • Patil HP, Gosavi M, Kulkarni R, Mishra AC, Arankalle VA. Immunoglobulin G Subclass Response After Chikungunya Virus Infection. Viral Immunol. 2022 Jul;35(6):437-442. doi: 10.1089/vim.2022.0055. Epub 2022 Jul 15. PMID: 35838586.
  • Doke P, Gothankar JS, Doke PP, Kulkarni MM, Khalate KK, Shrivastava S, Patil JR, Arankalle VA. Time dependent decline of neutralizing antibody titers in COVID-19 patients from Pune, India and evidence of reinfection. Microbes Infect. 2022 Jun;24(4):104979. doi: 10.1016/j.micinf.2022.104979. Epub 2022 Apr 20. PMID: 35452812; PMCID: PMC9020493.
  • Shrivastava, S., Mhaske, S. T., Modak, M. S., Virkar, R. G., Pisal, S. S., Mishra, A. C., & Arankalle, V. A. (2022). Emergence of two distinct variants of SARS-CoV-2 and an explosive second wave of COVID-19: the experience of a tertiary care hospital in Pune, India. Archives of virology, 167(2), 393–403. https://doi.org/10.1007/s00705-021-05320-7. 
  • Shrivastava S, Chelluboina S, Jedge P, Doke P, Palkar S, Mishra AC, Arankalle VA. Elevated Levels of Neutrophil Activated Proteins, Alpha-Defensins (DEFA1), Calprotectin (S100A8/A9) and Myeloperoxidase (MPO) Are Associated With Disease Severity in COVID-19 Patients. Front Cell Infect Microbiol. 2021 Oct 21;11:751232. doi: 10.3389/fcimb.2021.751232. PMID: 34746027; PMCID: PMC8566808.
  • Malshe, N., Patnaik, S. K., Lalwani, S., Suryawanshi, P., Kulkarni, R., Mhaske, S., Mishra, A. C., & Arankalle, V. (2022). Perinatal transmission of SARS-CoV-2 and transfer of maternal IgG/neutralizing anti-SARS-CoV-2 antibodies from mothers with asymptomatic infection during pregnancy. Infection, 50(1), 131–137. https://doi.org/10.1007/s15010-021-01650-5 

  • Kulkarni, R., Shrivastava, S., Patil, H. P., Kore, P., Rane, P., Palkar, S., Lalwani, S., Mishra, A. C., & Arankalle, V. A. (2021). Performance assessment of SARS-CoV-2 IgM & IgG ELISAs in comparison with plaque reduction neutralization test. The Indian journal of medical research, 153(5&6), 658–664. https ://doi.org/10.4103/ijmr.IJMR_3806_20 
  • Shrivastava, S., Palkar, S., Shah, J., Rane, P., Lalwani, S., Mishra, A. C., & Arankalle, V. A. (2021). Early and High SARS-CoV-2 Neutralizing Antibodies Are Associated with Severity in COVID-19 Patients from India. The American journal of tropical medicine and hygiene, 105(2), 401–406. https ://doi.org/10.4269/ajtmh.21-0014 
  • Tiraki, D., Singh, K., Shrivastava, S., Mishra, A. C., & Arankalle, V. (2021). Complete genome characterization and evolutionary analysis of dengue viruses isolated during 2016-2017 in Pune, India. Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases, 93, 104909. https ://doi.org/10.1016/j.meegid.2021.104909 
  • Kulkarni-Munje, A., Malshe, N., Palkar, S., Amlekar, A., Lalwani, S., Mishra, A. C., & Arankalle, V. (2021). Immune Response of Indian Preterm Infants to Pentavalent Vaccine Varies With Component Antigens and Gestational Age. Frontiers in immunology, 12, 592731. https ://doi.org/10.3389/fimmu.2021.592731 
  • Shrivastava, S., Patil, H. P., Mhaske, S. T., Palkar, S., Lalwani, S., Mishra, A. C., & Arankalle, V. A. (2021). Isolation and genetic characterization of SARS-CoV-2 from Indian patients in a single family without H/O travel abroad. Virus genes, 57(3), 245–249. https ://doi.org/10.1007/s11262-021-01826-z 
  • Patil, H. P., Rane, P. S., Shrivastava, S., Palkar, S., Lalwani, S., Mishra, A. C., & Arankalle, V. A. (2021). Antibody (IgA, IgG, and IgG Subtype) Responses to SARS-CoV-2 in Severe and Nonsevere COVID-19 Patients. Viral immunology, 34(3), 201–209. https ://doi.org/10.1089/vim.2020.0321 
  • Patil, H. P., Gosavi, M., Mishra, A. C., & Arankalle, V. A. (2021). Age-Dependent Evaluation of Immunoglobulin G Response after Chikungunya Virus Infection. The American journal of tropical medicine and hygiene, 104(4), 1438–1443. https ://doi.org/10.4269/ajtmh.20-1398 
  • Kulkarni-Munje, A., Palkar, S., Shrivastava, S., Lalwani, S., Mishra, A. C., & Arankalle, V. A. (2021). Disease-duration based comparison of subsets of immune cells in SARS CoV-2 infected patients presenting with mild or severe symptoms identifies prognostic markers for severity. Immunity, inflammation and disease, 9(2), 419–434. https ://doi.org/10.1002/iid3.402  
  • Kulkarni, R., Patil, H. P., Palkar, S., Lalwani, S., Mishra, A. C., & Arankalle, V. (2021). Anti-SARS-CoV-2 IgG antibody response among Indian COVID-19 patients using β-propiolactone-inactivated, whole virus-based indirect ELISA. Journal of virological methods, 287, 113996.https ://doi.org/10.1016/j.jviromet.2020.113996  

  • Patil, H. P., Rane, P. S., Gosavi, M., Mishra, A. C., & Arankalle, V. A. (2020). Standardization of ELISA for anti-chikungunya-IgG antibodies and age-stratified prevalence of anti-chikungunya-IgG antibodies in Pune, India. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 39(10), 1925–1932. https ://doi.org/10.1007/s10096-020-03933-5
  • Kulkarni, R., Shrivastava, S., Patil, H. P., Tiraki, D., Mishra, A. C., & Arankalle, V. A. (2020). Correlation of serostatus and viraemia levels among Indian dengue patients at the time of first diagnosis. Transactions of the Royal Society of Tropical Medicine and Hygiene, 114(7), 513–520. https ://doi.org/10.1093/trstmh/traa027
  • Shrivastava S, Solaskar A, Gosavi M, Tiraki D, Mishra AC, Arankalle VA. Evaluation of NS1-Detection-Based Cell Culture Method for Isolation of Dengue Viruses from Clinical Samples. SN Compr. Clin. Med. 2020;2:613–618.
  • Kulkarni R, Modak M, Gosavi M, Wani D, Mishra AC, Arankalle VA. Comparative assessment of commercial enzyme-linked immunosorbent assay & rapid diagnostic tests used for dengue diagnosis in India. Indian J Med Res. 2020 Jan;151(1):71-78. doi: 10.4103/ijmr.IJMR_613_18. PMID: 32134017; PMCID: PMC7055168.

  • Arankalle, V. A., Kulkarni, R., Malshe, N., Palkar, S., Lalwani, S., & Mishra, A. C (2019). Seroepidemiology of respiratory syncytial virus in western India with special reference to appropriate age for infant vaccination. Journal of medical virology, 91(8), 1566–1570. https ://doi.org/10.1002/jmv.25489
  • Malshe, N., Palkar, S., Kulkarni, R., Lalwani, S., Mishra, A. C., & Arankalle, V. (2019). Early disappearance of maternal anti-measles, mumps, rubella, and varicella antibodies in Indian infants. Vaccine, 37(11), 1443–1448. https ://doi.org/10.1016/j.vaccine.2019.01.043
  • Arankalle, V., Tiraki, D., Kulkarni, R., Palkar, S., Malshe, N., Lalwani, S., & Mishra, A. (2019). Age-stratified anti-HAV positivity in Pune, India after two decades: Has voluntary vaccination impacted overall exposure to HAV?. Journal of viral hepatitis, 26(6), 757–760. https ://doi.org/10.1111/jvh.13074
  • Kulkarni, R., Tiraki, D., Wani, D., Mishra, A. C., & Arankalle, V. A. (2019). Risk of transfusion-associated dengue: screening of blood donors from Pune, western India. Transfusion, 59(2), 458–462. https ://doi.org/10.1111/trf.15007

  • Mishra, A. C., Arankalle, V. A., Gadhave, S. A., Mahadik, P. H., Shrivastava, S., Bhutkar, M., & Vaidya, V. M. (2018). Stratified sero-prevalence revealed overall high disease burden of dengue but suboptimal immunity in younger age groups in Pune, India. PLoS neglected tropical diseases, 12(8), e0006657. https ://doi.org/10.1371/journal.pntd.0006657
  • Shrivastava, S., Tiraki, D., Diwan, A., Lalwani, S. K., Modak, M., Mishra, A. C., & Arankalle, V. A. (2018). Co-circulation of all the four dengue virus serotypes and detection of a novel clade of DENV-4 (genotype I) virus in Pune, India during 2016 season. PloS one, 13(2), e0192672. https ://doi.org/10.1371/journal.pone.0192672

 

Apply For

ADMISSIONS 2023
mobile-chat

Chat Now

 mobile-phone

Admission Helpline +91-20-24407100

mobile-inquiry

Quick Enquiry
National Immunogenicity & Biologics Evaluation Center ICMR Centre for Advanced Research Indian Council of Agricultural Research-LVAC
communicable-diseases Communicable Diseases obesity-and-diabetes Obesity & Diabetes cancer Cancer Research Lab herbal-medicine Herbal Medicine nutrition-health-disease Centre for Innovation in Nutrition Health Disease mother-and-child-health Mother & Child Health